Melatonin demonstrates oncostatic efficacy in hepatocellular carcinoma (HCC) through dual-pathway modulation: suppressing NF-κB transcriptional activation while attenuating TNF-α-mediated proinflammatory cascades (Ozturk et al., 2023). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.